Consumption of artificially and sugar-sweetened beverages and incident type 2 diabetes in the Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l’Education Nationale–European Prospective Investigation into Cancer and Nutrition cohort1234
Cited by (0)
- 1
From the Institut National de la Santé et de la Recherche Médicale U1018, Center for Research in Epidemiology and Population Health, Villejuif, France (GF, AV, ML, BB, and FC-C); the Paris-South University, Villejuif, France (GF, AV, ML, BB, and FC-C); the Department of Social Medicine, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil (DSS); and the Center for Research on Population Health, National Institute of Public Health of Mexico, Cuernavaca, Mexico (ML).
- 2
Study sponsors had no role in the design of the study, the analysis or interpretation of data, the writing of the manuscript, or the decision to submit the manuscript for publication.
- 3
Supported by the Institut National du Cancer, the Mutuelle Générale de l’Education Nationale, the Institut de Cancérologie Gustave Roussy, and the Institut National de la Santé et de la Recherche Médicale. The validation of potential diabetes cases was supported by the European Union (Integrated Project LSHM-CT-2006-037197 in the Framework Programme 6 of the European Community) InterAct project.
- 4
Address reprint requests and correspondence to F Clavel-Chapelon, Center for Research in Epidemiology and Population Health, Institut National de la Santé et de la Recherche Médicale U1018, Team 9, Nutrition, Hormones and Women’s Health, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94805 Villejuif Cedex, France. E-mail: [email protected]
- 5
Abbreviations used: ASB, artificially sweetened beverage; E3N, Etude Epidémiologique auprès des femmes de la Mutuelle Générale de l’Education Nationale; SSB, sugar-sweetened beverage; T2D, type 2 diabetes.